Qiagen NV (NYSE:QGEN)
| 48.75 Delayed Data As of 3:39pm ET |  -0.07 / -0.14%Today’s Change | 40.38 Today|||52-Week Range 51.30 | -2.25% Year-to-Date |
Latest QGEN News | Press Releases
| Bank of Italy's Top 5 Buys of the 4th Quarter 1:00pm / GuruFocus News - Paid Partner Content | QIAGEN's (QGEN) New Launch to Enhance Clinical Lab Workflow Jan 24 / Zacks.com - Paid Partner Content |
| Qiagen (QGEN) Expected to Beat Earnings Estimates: Can the Stock Move Higher? 10:01am / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 48.82 |
| Today’s open | 49.27 |
| Day’s range | 48.44 - 48.86 |
| Volume | 214,771 |
| Average volume (3 months) | 976,702 |
| Market cap | $11.2B |
Data as of 3:39pm ET, 01/31/2023
Growth & Valuation
| Earnings growth (last year) | +42.99% |
| Earnings growth (this year) | -13.13% |
| Earnings growth (next 5 years) | +2.80% |
| Revenue growth (last year) | +20.39% |
| P/E ratio | 24.3 |
| Price/Sales | 5.73 |
| Price/Book | 3.61 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BIOBio Rad Laboratories... | +0.99 | +0.21% |
| BRKRBruker Corp | -0.52 | -0.74% |
| PKIPerkinElmer Inc | +1.46 | +1.08% |
| ---- |
Data as of 3:40pm ET, 01/31/2023
Financials
| Next reporting date | February 8, 2023 |
| EPS forecast (this quarter) | $0.47 |
| Annual revenue (last year) | $2.3B |
| Annual profit (last year) | $512.6M |
| Net profit margin | 22.77% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Venlo, Limburg |
Forecasts
